Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1106540

Acromegaly and cancer


Radman, Maja; Miličević, Tanja
Acromegaly and cancer // Endocrine Oncology and Metabolism, 2 (2016), 1; 34-41 doi:10.21040/eom/2016.2.4 (domaća recenzija, članak, stručni)


CROSBI ID: 1106540 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
Acromegaly and cancer

Autori
Radman, Maja ; Miličević, Tanja

Izvornik
Endocrine Oncology and Metabolism (1849-8922) 2 (2016), 1; 34-41

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, stručni

Ključne riječi
Acromegaly ; Growth hormone ; Insulin-like Growth Factor-I ; Cancer risk ; Morbidity ; Mortality

Sažetak
Acromegaly is a chronic disease characterized by sustained elevation of circulating growth hormone (GH) and insulin-like growth factor-I (IGF-I). It is clearly associated with increased morbidity and overall mortality, primarily due to cardiovascular, metabolic, and respiratory diseases. Although the influence of acromegaly on carcinogenesis remains controversial, numerous studies have confirmed that acromegalic patients are at an increased risk of developing different types of neoplasms. Endangered patients are especially those who have been untreated for a long period and show increased serum concentrations of GH and IGF-I. Prevention and early detection of potential neoplasms remain a crucial part of treatment. This review will focus on the occurrence and mortality of benign and malignant tumors in acromegalic patients.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti



POVEZANOST RADA


Ustanove:
KBC Split,
Medicinski fakultet, Split

Profili:

Avatar Url Tanja Miličević (autor)

Avatar Url Maja Radman (autor)

Citiraj ovu publikaciju

Radman, Maja; Miličević, Tanja
Acromegaly and cancer // Endocrine Oncology and Metabolism, 2 (2016), 1; 34-41 doi:10.21040/eom/2016.2.4 (domaća recenzija, članak, stručni)
Radman, M. & Miličević, T. (2016) Acromegaly and cancer. Endocrine Oncology and Metabolism, 2 (1), 34-41 doi:10.21040/eom/2016.2.4.
@article{article, year = {2016}, pages = {34-41}, DOI = {10.21040/eom/2016.2.4}, keywords = {Acromegaly, Growth hormone, Insulin-like Growth Factor-I, Cancer risk, Morbidity, Mortality}, journal = {Endocrine Oncology and Metabolism}, doi = {10.21040/eom/2016.2.4}, volume = {2}, number = {1}, issn = {1849-8922}, title = {Acromegaly and cancer}, keyword = {Acromegaly, Growth hormone, Insulin-like Growth Factor-I, Cancer risk, Morbidity, Mortality} }
@article{article, year = {2016}, pages = {34-41}, DOI = {10.21040/eom/2016.2.4}, keywords = {Acromegaly, Growth hormone, Insulin-like Growth Factor-I, Cancer risk, Morbidity, Mortality}, journal = {Endocrine Oncology and Metabolism}, doi = {10.21040/eom/2016.2.4}, volume = {2}, number = {1}, issn = {1849-8922}, title = {Acromegaly and cancer}, keyword = {Acromegaly, Growth hormone, Insulin-like Growth Factor-I, Cancer risk, Morbidity, Mortality} }

Citati





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font